Status: Recruiting
Nebulized Ketamine for the Treatment of Major Depressive Disorder
This is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.
Participants needed: 40
Trial details
Phase: Phase 3Age: 18-88Biological sex: AllType: InterventionalSponsor: Theresa Jacob, PhD, MPHUpdated: Apr 24, 2026Locations: 1
Eligibility criteria
All individuals 18 years and older with a Montgomery-Asberg Depression Rating Sc... [+2]
Adult patients with an allergy to Ketamine [+14]